Adage Capital Partners’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-400,000	Closed	-$5.52M	–	1017
2025 Q4	$5.52M	Sell	400,000 -2,375,000	-86%	-$55.9M	0.01%	751
2025 Q3	$67.8M	Buy	2,775,000 +250,000	+10%	+$6.09M	0.11%	185
2025 Q2	$58.3M	Sell	2,525,000 -1,129,574	-31%	-$29.8M	0.1%	198
2025 Q1	$98.7M	Buy	3,654,574 +592,824	+19%	+$22.3M	0.18%	114
2024 Q4	$164M	Buy	3,061,750 +986,750	+48%	+$52.2M	0.29%	56
2024 Q3	$94.3M	Sell	2,075,000 -252,896	-11%	-$11M	0.17%	114
2024 Q2	$97.5M	Sell	2,327,896 -447,776	-16%	-$21M	0.18%	112
2024 Q1	$105M	Buy	2,775,672 +1,420,197	+105%	+$30.9M	0.2%	107
2023 Q4	$14.5M	Buy	1,355,475 +205,475	+18%	+$1.78M	0.03%	515
2023 Q3	$11.6M	Buy	1,150,000 +250,000	+28%	+$2.88M	0.03%	533
2023 Q2	$10.7M	Hold	900,000	–	–	0.02%	564
2023 Q1	$10.9M	Buy	900,000 +198,934	+28%	+$3.31M	0.02%	599
2022 Q4	$9.23M	Buy	701,066 +301,066	+75%	+$4.41M	0.02%	655
2022 Q3	$5.42M	Hold	400,000	–	–	0.01%	770
2022 Q2	$4.88M	Hold	400,000	–	–	0.01%	801
2022 Q1	$5.74M	Hold	400,000	–	–	0.01%	811
2021 Q4	$7.89M	Hold	400,000	–	–	0.01%	764
2021 Q3	$8.65M	Sell	400,000 -50,000	-11%	-$1.44M	0.02%	735
2021 Q2	$11.2M	Buy	+450,000	New	+$10M	0.02%	657